Kymera Therapeutics, Inc. (KYMR)
107.39
-2.73
(-2.48%)
USD |
NASDAQ |
Oct 02, 16:00
107.48
+0.09
(+0.08%)
After-Hours: 20:00
Kymera Therapeutics Price : 107.39 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 111.23 | 111.23 | 106.53 | 107.39 | 870206.0 |
| Oct 01, 2026 | 111.79 | 116.20 | 109.41 | 110.12 | 1.051M |
| Sep 30, 2026 | 110.74 | 115.69 | 108.03 | 111.79 | 1.023M |
| Sep 29, 2026 | 110.54 | 111.92 | 108.97 | 110.51 | 448209.0 |
| Sep 28, 2026 | 111.95 | 113.60 | 110.51 | 112.00 | 723653.0 |
| Sep 25, 2026 | 115.99 | 116.20 | 111.42 | 111.95 | 698434.0 |
| Sep 24, 2026 | 115.28 | 116.40 | 111.36 | 115.81 | 841723.0 |
| Sep 23, 2026 | 121.29 | 123.00 | 112.91 | 115.47 | 969616.0 |
| Sep 22, 2026 | 119.03 | 122.37 | 117.88 | 122.06 | 779427.0 |
| Sep 21, 2026 | 117.75 | 119.53 | 116.61 | 117.67 | 636938.0 |
| Sep 18, 2026 | 119.06 | 119.06 | 116.36 | 117.75 | 1.900M |
| Sep 17, 2026 | 119.12 | 122.13 | 118.27 | 118.48 | 570489.0 |
| Sep 16, 2026 | 113.06 | 117.43 | 112.88 | 116.33 | 655793.0 |
| Sep 15, 2026 | 114.50 | 114.50 | 110.29 | 113.15 | 900978.0 |
| Sep 14, 2026 | 116.01 | 117.85 | 114.32 | 114.63 | 499014.0 |
| Sep 11, 2026 | 118.40 | 119.93 | 113.74 | 114.96 | 574186.0 |
| Sep 10, 2026 | 116.05 | 119.63 | 114.35 | 117.00 | 734300.0 |
| Sep 09, 2026 | 115.34 | 120.66 | 113.18 | 115.43 | 767425.0 |
| Sep 08, 2026 | 114.41 | 120.22 | 113.97 | 116.47 | 631822.0 |
| Sep 04, 2026 | 115.09 | 118.28 | 112.77 | 117.39 | 378568.0 |
| Sep 03, 2026 | 118.63 | 119.26 | 115.55 | 117.28 | 591615.0 |
| Sep 02, 2026 | 119.58 | 123.54 | 117.42 | 118.63 | 982968.0 |
| Sep 01, 2026 | 116.92 | 119.78 | 116.28 | 119.05 | 576626.0 |
| Aug 31, 2026 | 118.60 | 119.93 | 115.97 | 118.81 | 656834.0 |
| Aug 28, 2026 | 119.40 | 121.98 | 117.48 | 118.15 | 415947.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 64.19 |
| Oncolytics Biotech, Inc. | 0.631 |
| Sangamo Therapeutics, Inc. | 0.1475 |
| Sarepta Therapeutics, Inc. | 17.50 |
| Anixa Biosciences, Inc. | 2.95 |
Price Related Metrics
| PS Ratio | 95.35 |
| Price to Book Value | 5.891 |
| Earnings Yield | -3.02% |
| Market Cap | 8.891B |